Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļRVTY
āļāļ·āđāļāļāļĢāļīāļĐāļąāļRevvity Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 12, 2101
āļāļĩāļāļĩāđāļSingh (Prahlad R)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ11000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļAug 12
āļāļĩāđāļāļĒāļđāđ77 4Th Avenue
āđāļĄāļ·āļāļWALTHAM
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ02451
āđāļāļĢāļĻāļąāļāļāđ17816636900
āđāļ§āđāļāđāļāļāđhttps://www.revvity.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļRVTY
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 12, 2101
āļāļĩāļāļĩāđāļSingh (Prahlad R)
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
Dr. Peter Barrett, Ph.D.
Independent Director
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
Ms. Pascale Witz
Independent Director
Mrs. Anita Gonzales
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
Mr. Michael A. Klobuchar
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
Dr. Peter Barrett, Ph.D.
Independent Director
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
First Trust Indxx Medical Devices ETF
Invesco S&P 500 Equal Weight Health Care ETF
T Rowe Price Capital Appreciation Equity ETF
ROBO Global Healthcare Technology & Innovation ETF
First Trust Health Care Alphadex Fund
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
VanEck Morningstar SMID Moat ETF
Neuberger Berman Small-Mid Cap ETF
NYLI Candriam US Mid Cap Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ2.12%
Invesco S&P 500 Equal Weight Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.85%
T Rowe Price Capital Appreciation Equity ETF
āļŠāļąāļāļŠāđāļ§āļ1.36%
Simplify Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.29%
ROBO Global Healthcare Technology & Innovation ETF
āļŠāļąāļāļŠāđāļ§āļ1.16%
First Trust Health Care Alphadex Fund
āļŠāļąāļāļŠāđāļ§āļ0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
āļŠāļąāļāļŠāđāļ§āļ0.84%
VanEck Morningstar SMID Moat ETF
āļŠāļąāļāļŠāđāļ§āļ0.64%
Neuberger Berman Small-Mid Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.56%
NYLI Candriam US Mid Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.5%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
137.14M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 08, 2026 going ex on Apr 17, 2026
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ